Prognostic Value of Volumetric Parameters of Pretreatment 18F-FDG PET/CT in Esophageal Cancer: A Systematic Review and Meta-analysis
- 1 December 2018
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Nuclear Medicine
- Vol. 43 (12), 887-894
- https://doi.org/10.1097/RLU.0000000000002291
Abstract
Purpose We performed a systematic review and meta-analysis on the prognostic value of metabolic tumor volume (MTV) and total lesion glycolysis (TLG) derived from pretreatment F-18-FDG PET/CT in patients with esophageal cancer. Methods PubMed and EMBASE databases were searched until April 12, 2018, for studies that evaluated MTV or TLG as prognostic factors in esophageal cancer, with overall survival (OS) and event-free survival serving as the end points. Hazard ratios (HRs) were meta-analytically pooled using a random-effects model. Subgroup analyses based on the clinicopathological and PET variables were performed. Results In total, 16 studies with 1294 patients were included. The pooled HRs of MTV and TLG for OS were 2.26 (95% confidence interval [CI], 1.73-2.96) and 2.23 (95% CI, 1.73-2.87), respectively. Regarding event-free survival, the pooled HRs of MTV and TLG were 2.03 (95% CI, 1.66-2.49) and 2.57 (95% CI, 1.82-3.62), respectively. Metabolic tumor volume was found to be a significant prognostic factor for OS consistently across multiple subgroups classified based on stage, histological subtype, treatment, delineation of volume of interest, and the determination method of cutoff value, with pooled HRs ranging from 1.96 to 2.54. Conclusions In patients with esophageal cancer, MTV and TLG derived from pretreatment F-18-FDG PET are significant prognostic factors. As prognostic biomarkers, volumetric metabolic parameters may bolster the role of F-18-FDG PET in the management of esophageal cancer.This publication has 36 references indexed in Scilit:
- Endoscopic Tumor Length Is an Independent Prognostic Factor in Esophageal Squamous Cell CarcinomaAnnals of Surgical Oncology, 2012
- Prognostic value of metabolic volume measured by F-18 FDG PET-CT in patients with esophageal cancerThoracic Cancer, 2012
- Impact of Partial-Volume Effect Correction on the Predictive and Prognostic Value of Baseline 18F-FDG PET Images in Esophageal CancerJournal of Nuclear Medicine, 2012
- Impact of a multidisciplinary tumour board meeting for upper-GI malignancies on clinical decision making: a prospective cohort studyInternational Journal of Clinical Oncology, 2011
- Impact of [18F]FDG PET imaging parameters on automatic tumour delineation: need for improved tumour delineation methodologyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2011
- Effects of Image Characteristics on Performance of Tumor Delineation Methods: A Test–Retest AssessmentJournal of Nuclear Medicine, 2011
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaborationJournal of Clinical Epidemiology, 2009
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA StatementJournal of Clinical Epidemiology, 2009
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- Measuring inconsistency in meta-analysesBMJ, 2003